Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Diabetic Nephropathy | Research

ITGAM-mediated macrophages contribute to basement membrane damage in diabetic nephropathy and atherosclerosis

Authors: Yude Lou, Peng Hui Li, Xiao Qi Liu, Tian Xiang Wang, Yi Lan Liu, Chen Chen Chen, Kun Ling Ma

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Diabetic nephropathy (DN) and atherosclerosis (AS) are prevalent and severe complications associated with diabetes, exhibiting lesions in the basement membrane, an essential component found within the glomerulus, tubules, and arteries. These lesions contribute significantly to the progression of both diseases, however, the precise underlying mechanisms, as well as any potential shared pathogenic processes between them, remain elusive.

Methods

Our study analyzed transcriptomic profiles from DN and AS patients, sourced from the Gene Expression Omnibus database. A combination of integrated bioinformatics approaches and machine learning models were deployed to identify crucial genes connected to basement membrane lesions in both conditions. The role of integrin subunit alpha M (ITGAM) was further explored using immune infiltration analysis and genetic correlation studies. Single-cell sequencing analysis was employed to delineate the expression of ITGAM across different cell types within DN and AS tissues.

Results

Our analyses identified ITGAM as a key gene involved in basement membrane alterations and revealed its primary expression within macrophages in both DN and AS. ITGAM was significantly correlated with tissue immune infiltration within these diseases. Furthermore, the expression of genes encoding core components of the basement membrane was influenced by the expression level of ITGAM.

Conclusion

Our findings suggest that macrophages may contribute to basement membrane lesions in DN and AS through the action of ITGAM. Moreover, therapeutic strategies that target ITGAM may offer potential avenues to mitigate basement membrane lesions in these two diabetes-related complications.
Appendix
Available only for authorised users
Literature
13.
go back to reference Shen W, Song Z, Zhong X, et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022;1(3):e36.CrossRef Shen W, Song Z, Zhong X, et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022;1(3):e36.CrossRef
16.
go back to reference Sundermann B, Bode J, Lueken U, et al. Support vector machine analysis of functional magnetic resonance imaging of Interoception does not reliably predict individual outcomes of cognitive behavioral therapy in panic disorder with agoraphobia. Front Psychiatry. 2017;8:99.CrossRefPubMedPubMedCentral Sundermann B, Bode J, Lueken U, et al. Support vector machine analysis of functional magnetic resonance imaging of Interoception does not reliably predict individual outcomes of cognitive behavioral therapy in panic disorder with agoraphobia. Front Psychiatry. 2017;8:99.CrossRefPubMedPubMedCentral
17.
go back to reference Yang YY, Gao ZX, Mao ZH, Liu DW, Liu ZS, Wu P. Identification of ULK1 as a novel mitophagy-related gene in diabetic nephropathy. Front Endocrinol (Lausanne). 2023;13:1079465.CrossRefPubMed Yang YY, Gao ZX, Mao ZH, Liu DW, Liu ZS, Wu P. Identification of ULK1 as a novel mitophagy-related gene in diabetic nephropathy. Front Endocrinol (Lausanne). 2023;13:1079465.CrossRefPubMed
18.
go back to reference Guyon I, Weston J, Barnhill S, et al. Gene selection for Cancer classification using support vector machines. Mach Learn. 2002;46:389–422.CrossRef Guyon I, Weston J, Barnhill S, et al. Gene selection for Cancer classification using support vector machines. Mach Learn. 2002;46:389–422.CrossRef
20.
22.
Metadata
Title
ITGAM-mediated macrophages contribute to basement membrane damage in diabetic nephropathy and atherosclerosis
Authors
Yude Lou
Peng Hui Li
Xiao Qi Liu
Tian Xiang Wang
Yi Lan Liu
Chen Chen Chen
Kun Ling Ma
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03505-1

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.